C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/34 (2006.01) A61K 31/4196 (2006.01) A61K 31/4245 (2006.01) A61K 31/426 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 25/24 (2006.01) C07D 249/12 (2006.01) C07D 271/07 (2006.01) C07D 277/20 (2006.01) C07D 403/00 (2006.01) C07D 413/00 (2006.01) C07D 417/00 (2006.01) C11D 1/75 (2006.01) C11D 3/30 (2006.01)
Patent
CA 2344574
The invention provides thiazolidinedione, oxadiazolidinedione, and triazolone compounds of Formula (I): (see formula I) (in which X is a thiazolidinedione, oxadiazolidinedione or thiazolone ring bonded to the phenylene group optionally via CH2 or CH=; W is O, S, SO, SO2, CH2, CF2, CHF, CO, CH(OH) , NR a or C(=CH2) ; R1, R2, R3 and R6 are H, halo, etc.; R4 is H, alkyl, etc.; R5 is OH, O-alkyl, etc.; R a is H or alkyl) which are thyroid receptor ligands and are useful for treating obesity, overweight condition, hyperlipidemia, glaucoma, cardiac arrhythmias, skin disorders, thyroid disease, hypothyroidism, thyroid cancer, diabetes, atherosclerosis, hypertension, coronary heart disease, congestive heart failure, hypercholesterolemia, depression, and osteoporosis.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Thyroid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thyroid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thyroid receptor ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1402252